New research into Amyotrophic Lateral Sclerosis (ALS) – also known as motor neuron disease – shows that specific immune cells may help slow progression of the disease, an important step towards developing new therapies to treat patients.
New research into Amyotrophic Lateral Sclerosis (ALS) – also known as motor neuron disease – shows that specific immune cells may help slow progression of the disease, an important step towards developing new therapies to treat patients.